Stage IIB Skin Melanoma Completed Phase Trials for Benzalkonium (DB11105)

IndicationStatusPhase
DBCOND0054560 (Stage IIB Skin Melanoma)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01460875Recombinant Interferon Alfa-2b in Treating Patients With MelanomaTreatment